You are being redirected because this document is part of your ASTM Compass® subscription.
    This document is part of your ASTM Compass® subscription.

    STP1344

    Evaluation of Nebulizer Performance within the ICP-MS Measurement System for Analysis of SRS Radiological Waste Tank Simulated Solutions

    Published: 0


      Format Pages Price  
    PDF (200K) 10 $25   ADD TO CART
    Complete Source PDF (3.0M) 150 $59   ADD TO CART

    Cite this document

    X Add email address send
    X
      .RIS For RefWorks, EndNote, ProCite, Reference Manager, Zoteo, and many others.   .DOCX For Microsoft Word


    Abstract

    High level radioactive waste tanks at the Savannah River Site are high in salt content. The average Total Dissolved Solids (TDS) content is approximately 25%. For ICP-MS optimum signal stability and to reduce blockage of nebulizers and sampling orifices, it is usual to limit analyte solutions to a TDS content of nominally < 0.2%. Dilution to this level to reduce the matrix effect may push some analytes of interest below detectable levels. Five commercially available nebulizers were evaluated in a field study as part of the ICP-MS measurement system for their performance in a high salt matrix. The nebulizers surveyed were a meinhard concentric, cross-flow, micro-concentric (MCN), V-groove, and a direct injection nebulizer (DIN). Analytes spiked into non-radioactive diluted salt solutions ranging from nominal 0.25 – 1.0% TDS were repetitively analyzed with the goal of determining stability of response signal and magnitude of any signal loss/suppression resulting from the diluted salt matrix. The cross-flow nebulizer provided the most stable signal for all salt matrices with the smallest signal loss/suppression due to this matrix. The DIN exhibited a serious lack of tolerance for TDS; possibly due to physical de-tuning of the nebulizer efficiency.

    Keywords:

    inductively coupled plasma mass spectrometry, high salt matrix, meinhard concentric nebulizer, cross-flow nebulizer, micro-concentric nebulizer, V-groove nebulizer, direct injection nebulizer, signal loss and/or suppression


    Author Information:

    Jones, VD
    Principal chemist, Westinghouse Savannah River Company, Aiken, SC


    Committee/Subcommittee: C26.07

    DOI: 10.1520/STP15725S